Brace Integrated Services Competitors

Kaiser Permanente's Division of Research (DOR) is one of the nation’s largest research facilities outside of a government or university setting. Our studies cover a wide range of clinical topics, including cardiovascular disease, cancer, diabetes, substance abuse, mental health, maternal and child health, and women’s health. Our research addresses broad issues, including the role of genes and the environment in health, the influence of behavior on disease prevention and chronic illness management, drug safety, health care policy, health services delivery, and disparities. The Division is currently home to 75 research scientists and staff scientists, 17 research fellows, and more than 674 employees. The DOR also has 46 adjunct investigators from within Kaiser Permanente Northern California (KPNC) and other academic institutions. DOR’s scientists are involved in 612 ongoing research projects and the KPNC Clinical Trials Program supports and guides 326 active clinical trials following 3,917 members. Since 2000, DOR researchers have published more than 8,100 peer-reviewed articles, and across all KPNC researchers there were more than 1,000 papers published in 2025 alone.

USI is one of the largest insurance brokerage and consulting firms in the world, delivering property and casualty, employee benefits, personal risk, program and retirement solutions to large risk management clients, middle market companies, smaller firms and individuals. Headquartered in Valhalla, New York, USI connects nearly 11,000 industry-leading professionals across approximately 200 offices to serve clients’ local, national and international needs. USI has become a premier insurance brokerage and consulting firm by leveraging the USI ONE Advantage®, an interactive platform that integrates proprietary and innovative client solutions, networked local resources and enterprise-wide collaboration to deliver customized results with positive, bottom-line impact. USI attracts best-in-class industry talent with a long history of deep and continuing investment in our local communities. For more information, visit usi.com.

At BASF, we create chemistry for a sustainable future. Our ambition: We want to be the preferred chemical company to enable our customers’ green transformation. We combine economic success with environmental protection and social responsibility. Around 108,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises, as core businesses, the segments Chemicals, Materials, Industrial Solutions, and Nutrition & Care; our standalone businesses are bundled in the segments Surface Technologies and Agricultural Solutions. Optimism is what drives all human beings. At BASF, this motivates us every day to develop solutions for the greatest challenges of our time – so we can better protect the climate, make optimal use of limited resources and provide food, energy and clean water for a booming world population. Our Research Focus: Overcoming the challenges of our time As a global leader in chemical R&D, BASF develops solutions for a sustainable future. Our research helps secure safe, high-quality food, advances cleaner and safer mobility through battery materials, and supports a circular economy with biobased products and new recycling processes. We also drive climate-smart production by improving energy efficiency, expanding renewable energy use and developing CO2-free technologies such as methane pyrolysis. Across hundreds of projects worldwide, our researchers help customers meet changing needs, regulations and sustainability goals. BASF generated sales of around €60 billion in 2025. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Credits: https://www.basf.com/global/en/legal/credits Data protection information: https://www.basf.com/global/en/legal/data-protection-at-basf.html